Fortive Monthly Analysis (March 2026)

Fortive

NYSE:FTV

$ 53,92

$-0,89 (-1,62%)

53,92 $

$-0,89 (-1,62%)

End-of-day quote: 03/27/2026

Fortive Stock Value

Analysts currently see Fortive at the level of Hold.

Hold

Fortive Company Info

EPS Growth 5Y

-2,40%

Market Cap

$16,60 B

Long-Term Debt

$2,31 B

Short Interest

3,05%

Annual earnings

N/A

Dividend

$0,24

Dividend Yield

0,44%

Founded

2015

Industry

Industrials

Country

United States

ISIN Number

US34959J1088

Website

http://www.fortive.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

$63,50

17.77%

Last Update: 03/28/2026

Analysts: 16

Highest Price Target $72,00

Average Price Target $63,50

Lowest Price Target $51,00

In the last five quarters, Fortive’s Price Target has fallen from $126,87 to $90,23 - a -28,88% decrease. Seventeen analysts predict that Fortive’s share price will increase in the coming year, reaching $63,50. This would represent an increase of 17,77%.

Top growth stocks in the industrials sector (5Y.)

What does Fortive do?

Fortive Corporation provides essential technologies for connected workflow solutions across a range of attractive end-markets. The company’s businesses design, develop, manufacture, and service professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. Segments The company operates through three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions....

Fortive Corporation provides essential technologies for connected workflow solutions across a range of attractive end-markets.

The company’s businesses design, develop, manufacture, and service professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions.

Segments

The company operates through three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions.

Intelligent Operating Solutions

Intelligent Operating Solutions segment provides advanced instrumentation, software and services to tens of thousands of customers enabling their mission-critical workflows. These offerings include electrical test & measurement, facility and asset lifecycle software applications, connected worker safety and compliance solutions across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications and electronics, among others.

Typical users of these safety, productivity and sustainability solutions include electrical engineers, electricians, electronic technicians, EHS professionals, network technicians, facility managers, first-responders, and maintenance professionals.

Products and services within the company’s Intelligent Operating Solutions segment are marketed under a variety of leading brands, including ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL.

Precision Technologies

Precision Technologies segment helps solve tough technical challenges to speed breakthroughs in a wide range of applications, from food and beverage production and manufacturing to next-generation electric vehicles and clean energy, as the company’s customers seek new test solutions to enable the electrification and connectivity of everything. The company’s expertise in materials, methods and measurements are reflected in its electrical test & measurement and sensing and material technologies offered to a broad set of customers and vertical end markets, including industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries. Customers for these products and services include design engineers for advanced electronic devices and equipment, process and quality engineers focused on improved process capability and productivity, facility maintenance managers driving increased uptime, and other customers for whom precise measurement, reliability, and compliance are critical in their applications.

Products and services in the company’s Precision Technologies segment are marketed under a variety of brands, including ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY and TEKTRONIX.

Advanced Healthcare Solutions

Advanced Healthcare Solutions segment supplies critical workflow solutions enabling healthcare providers to deliver exceptional patient care more efficiently. The company’s offerings include instrument sterilization solutions, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions. The company’s healthcare offerings help ensure critical safety standards are met, instruments and operating rooms are working at peak performance, and complex procedures are followed accurately in these mission-critical healthcare environments.

Products and services in the company’s Advanced Healthcare Solutions segment are marketed under a variety of brands, including ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, LANDAUER, PROVATION, RAYSAFE, and STERRAD.

Seasonal Nature of Business

General economic conditions impact the company’s business and financial results, and certain of its businesses experience seasonal and other trends related to the industries and end markets that they serve. For example, sales of capital equipment and sterilization consumables are often stronger in the fourth calendar quarter (year ended December 31, 2024) and sales to OEMs are often stronger immediately preceding and following the launch of new products.

Regulatory Matters

Many of the company’s products in the Advanced Healthcare Solutions segment are classified as medical devices and are subject to restrictions under domestic and foreign laws, rules, regulations, self-regulatory codes, circulars, and orders, including, but not limited to, the U.S. Food, Drug, and Cosmetic Act (the FDCA). The FDCA requires these products, when sold in the United States, to be safe and effective for their intended uses and to comply with the regulations administered by the U.S. Food and Drug Administration (FDA).

Any medical devices the company manufactures and distributes are subject to pervasive and continuing regulation by the FDA and certain state and certain other comparable foreign authorities. As a medical device manufacturer, the company’s manufacturing facilities are subject to inspection on a routine basis by the FDA and other comparable foreign authorities as well as audits by its notified body. The company is required to adhere to the Current Good Manufacturing Practices requirements, as set forth in the Quality Systems Regulation, as well as other applicable standards which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation, and other quality assurance procedures during all phases of the design and manufacturing process.

The company must also comply with global post-market surveillance regulations, including adverse event reporting requirements, which require that it reviews and reports to the FDA.

Given the international scope of operation, the company is subject to various U.S. and non-U.S. laws outlawing bribes, kickbacks, payoffs, and other improper payments. In particular, the U.S. Foreign Corrupt Practices Act (FCPA), the UK Bribery Act, and other similar laws in other jurisdictions prohibit companies, their officers and employees, and their intermediaries from making improper payments to public officials to influence those officials or secure an improper advantage in order to obtain or retain business. In the past several years, there has been a substantial increase in the enforcement of these global anti-bribery and anti-corruption laws.

The company sells products and services to customers all over the world and are required to comply with various U.S. export/import control and economic sanctions laws, such as:

the International Traffic in Arms Regulations administered by the U.S. Department of State, Directorate of Defense Trade Controls, which, among other things, impose license requirements on the export from the United States of defense articles and defense services listed on the United States Munitions List;

the Export Administration Regulations administered by the U.S. Department of Commerce, Bureau of Industry and Security, which, among other things, impose licensing requirements on the export, in-country transfer, and re-export of certain dual-use goods, technology, and software (which are items that have both commercial and military or proliferation applications);

the regulations administered by the U.S. Department of Treasury, Office of Foreign Assets Control, which implement economic sanctions imposed against designated countries, governments, and persons based on United States foreign policy and national security considerations; and

the import regulations administered by U.S. Customs and Border Protection.

International Operations

The company's products and services are available in markets worldwide, with its principal markets outside the United States being in Europe and Asia. The manner in which the company's products and services are sold outside the United States differs by business and by region. Most of its sales in non-U.S. markets are made by its subsidiaries located outside the United States, though it also sells directly from the United States into non-U.S. markets through various representatives and distributors and, in some cases, directly. In countries with low sales volumes, the company generally sells through representatives and distributors.

History

Fortive Corporation was incorporated in Delaware in 2015.

Fortive Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Industry and Measurement Solutions:** approx. 40% **Intelligent Operating Platforms:** approx. 35% **Health Solutions:** approx. 25% **TOP 3 Markets:** **USA:** approx. 45% **Europe:** approx. 30% **Asia-Pacific:** approx. 20% Fortive Corporation mainly generates its revenues from...

At which locations are the company’s products manufactured?

**Production Sites:** Globally distributed, with focal points in the USA, Europe, and Asia. Fortive Corporation is a diversified industrial company that operates worldwide. The company manufactures its products at various locations around the globe to effectively serve its international markets. Th...

What strategy does Fortive pursue for future growth?

**Strategy for Future Growth:** 1. **Portfolio Diversification:** Fortive Corporation continues to focus on diversifying its portfolio through strategic acquisitions and investments in high-growth segments. This includes expanding solutions in digital technologies and automation. 2. **Focus on Sus...

Which raw materials are imported and from which countries?

**Main raw materials:** Electronic components, metals, plastics **Countries of origin:** China, Germany, Japan, South Korea Fortive Corporation is a diversified industrial company operating in various sectors, including measurement and control technologies. The main raw materials imported by Forti...

How strong is the company’s competitive advantage?

**Market Share:** 10% in the measurement technology industry (2024, estimate) **EBITDA Margin:** 25% (2024) **R&D Expenses:** 6% of revenue (2024) Fortive Corporation has a significant competitive advantage due to its strong market position in the measurement technology industry, where it h...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** 85% (estimated, 2025) **Insider Buys/Sells:** No significant transactions in the last year (2025) The institutional investor share in Fortive Corporation is estimated to be around 85%. This suggests that a large portion of the shares are held by major institution...

What percentage market share does Fortive have?

**Market Share of Fortive Corporation:** Estimated 8-10% (2025) **Top Competitors and Their Market Shares:** 1. **Danaher Corporation:** 15-17% 2. **Honeywell International Inc.:** 12-14% 3. **3M Company:** 10-12% 4. **Fortive Corporation:** 8-10% 5. **ABB Ltd:** 6-8% 6. **Siemens AG:** 5-7% 7. **E...

Is Fortive stock currently a good investment?

**Revenue Growth:** 8% (2024) **Profit Growth:** 10% (2024) **Market Share in Core Segments:** Stable Fortive Corporation recorded a revenue growth of 8% and a profit growth of 10% in 2024. These growth rates indicate a solid financial performance supported by strong operational efficiency and succ...

Does Fortive pay a dividend – and how reliable is the payout?

**Dividend Yield:** 0.4% (2024) Fortive Corporation pays a dividend, however, the dividend yield of 0.4% is relatively low compared to other companies in the industry. Fortive's dividend policy is conservative, indicating that the company places a greater focus on reinvestments and growth. Th...

New support ticket

Explore

Fortive Stock Value

Fortive Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Fortive do?

Fortive Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Fortive Stock Value

Fortive Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the industrials sector (5Y.)

What does Fortive do?

Fortive Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.